References
- SelkoeDJHardyJThe amyloid hypothesis of Alzheimer’s disease at 25 yearsEMBO Mol Med20168659560827025652
- MawuenyegaKGSigurdsonWOvodVDecreased clearance of CNS β-amyloid in Alzheimer’s diseaseScience2010330177421148344
- KawaguchiKKitaguchiNNakaiSNovel therapeutic approach for Alzheimer’s disease by removing amyloid beta protein from the brain with an extracorporeal removal systemJ Artif Organs2010131313720177724
- KawaguchiKTakeuchiMYamagawaHA potential therapeutic system for Alzheimer’s disease using adsorbents with alkyl ligands for removal of blood amyloid βJ Artif Organs201316221121723212279
- KawaguchiKSaigusaAYamadaSToward the treatment for Alzheimer’s disease: adsorption is primary mechanism of removing amyloid β protein with hollow-fiber dialyzers of the suitable materials, polysulfone and polymethyl methacrylateJ Artif Organs201619214915826686230
- KitaguchiNKawaguchiKYamazakiKAdsorptive filtration systems for effective removal of blood amyloid β: a potential therapy for Alzheimer’s diseaseJ Artif Organs201821222022929230564
- KitaguchiNKawaguchiKNakaiSReduction of Alzheimer’s disease amyloid-β in plasma by hemodialysis and its relation to cognitive functionsBlood Purif2011321576221346337
- KatoMKawaguchiKNakaiSPotential therapeutic system for Alzheimer’s disease: removal of blood Aβs by hemodialzyers and its effect on the cognitive functions of renal-failure patientsJ Neural Transm2012119121533154422699459
- KitaguchiNHasegawaMItoSA prospective study on blood Aβ levels and the cognitive function of patients with hemodialysis: a potential therapeutic strategy for Alzheimer’s diseaseJ Neural Transm2015122111593160726228626
- SakaiKSendaTHataRPatients that have Undergone Hemodialysis Exhibit Lower Amyloid Deposition in the Brain: Evidence Supporting a Therapeutic Strategy for Alzheimer’s Disease by Removal of Blood AmyloidJ Alzheimers Dis2016514997100226923028
- NakaiSWakaiKKandaEKawaguchiKSakaiKKitaguchiNIs hemodialysis itself a risk factor for dementia? An analysis of nationwide registry data of patients on maintenance hemodialysis in JapanRenal Replacement Therapy20184112
- BoadaMOrtizPAnayaFAmyloid-targeted therapeutics in Alzheimer’s disease: use of human albumin in plasma exchange as a novel approach for Abeta mobilizationDrug News Perspect200922632523919771322
- JinWSShenLLBuXLPeritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse modelActa Neuropathol2017134220722028477083
- WoodHAlzheimer disease: Peripheral Aβ clearance – a therapeutic strategy for AD?Nat Rev Neurol2017137386
- PetersenRCDoodyRKurzACurrent concepts in mild cognitive impairmentArch Neurol200158121985199211735772
- SugishitaMAsadaTCreating Geriatric Depression Scale-Short Version-Japanese, GDS-S-JJpn J Cognit Neurosci2009118790
- FazekasFChawlukJBAlaviAHurtigHIZimmermanRAMR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal agingAJR Am J Roentgenol198714923513563496763
- HachinskiVCIliffLDZilhkaECerebral blood flow in dementiaArch Neurol19753296326371164215
- KanekoNNakamuraAWashimiYNovel plasma biomarker surrogating cerebral amyloid depositionProc Jpn Acad Ser B Phys Biol Sci2014909353364
- ZhouLSalvadoODoreVMR-less surface-based amyloid assessment based on 11C PiB PETPLoS One201491e8477724427295
- SevignyJChiaoPBussièreTThe antibody aducanumab reduces Aβ plaques in Alzheimer’s diseaseNature20165377618505627582220
- KitaguchiNKawaguchiKKinomuraJExtracorporeal Blood Aβ Removal System (EBARS) reduced soluble Aβ in the brain by triggering influx into the blood: rat studiesPoster presented at: Alzheimer’s Association International Conference AAICJuly 17, 2017London
- SallowaySMarshallGALuMBrashearHRLong-Term Safety and Efficacy of Bapineuzumab in Patients with Mild-To-Moderate Alzheimer’s Disease: A Phase 2, Open Label Extension StudyCurr Alzheimer Res Epub2018820
- SakaiKSendaTHataREvidence supporting a therapeutic strategy for Alzheimer’s disease by removal of blood amyloid; Patients that have undergone hemodialysis exhibit lower Amyloid deposition in the brainPoster presented at: Alzheimer’s Association International Conference AAICJuly 25, 2016Toronto
- HilalSWoltersFJVerbeekMMPlasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based studyAlzheimers Res Ther20181016329960604
- KoyamaAOkerekeOIYangTBlackerDSelkoeDJGrodsteinFPlasma amyloid-β as a predictor of dementia and cognitive decline: A systematic review and meta-analysisArch Neurol20126982483122451159
- BugnicourtJMGodefroyOChillonJMChoukrounGMassyZACognitive disorders and dementia in CKD: the neglected kidney-brain axisJ Am Soc Nephrol201324335336323291474
- LabriolaLJadoulMDialysis-related Amyloidosis: Is It Gone or Should It Be?Semin Dial201730319319628264226
- MorikawaHOhashiNKawaguchiKPotential therapeutic system for Alzheimer’s disease by removal of blood Aβ; Efficient Aβ removal system by enhancing adsorption on hollow fibers with hemodiafiltrationPoster presented at: Alzheimer’s Association International Conference AAICJuly 25, 2016Toronto